SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023

We conducted a serologic and molecular study to assess exposure of captive nonhuman primates (NHPs) to SARS-CoV-2 in Spain during the 2020-2023 COVID-19 pandemic. We found limited exposure of NHPs to SARSCoV-2. Biosafety measures must be strictly maintained to avoid SARS-CoV-2 reverse-zoonotic trans...

Descripción completa

Detalles Bibliográficos
Autores: Cano-Terriza, David|||0000-0001-5657-2567, Beato-Benítez, Adrián, Fernández-Bastit, Leira|||0000-0002-7766-939X, Segalés Coma, Joaquim|||0000-0002-1539-7261, Vergara-Alert, Júlia|||0000-0001-7484-444X, Martínez-Nevado, Eva, Carretero, Andrea, Crailsheim, Dietmar, Soriano Sáez, Pilar, Planas, Javier, Torro, Mario, García Bocanegra, Ignacio|||0000-0003-3388-2604
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:307692
Acceso en línea:https://ddd.uab.cat/record/307692
https://dx.doi.org/urn:doi:10.3201/eid3006.231247
Access Level:acceso abierto
Palabra clave:SDG 3 - Good Health and Well-being
Coronavirus disease
Nonhuman primates
Respiratory infections
Severe acute respiratory syndrome coronavirus 2
Zoonoses
Descripción
Sumario:We conducted a serologic and molecular study to assess exposure of captive nonhuman primates (NHPs) to SARS-CoV-2 in Spain during the 2020-2023 COVID-19 pandemic. We found limited exposure of NHPs to SARSCoV-2. Biosafety measures must be strictly maintained to avoid SARS-CoV-2 reverse-zoonotic transmission in the human-NHP interface.

Similares en LA Referencia